ClinicalTrials.Veeva

Menu

Influence of Diuresis Timing (F+0 Vs F-15) on 99m Tc DTPA Renography for the Diagnosis of Suspected Obstructive Uropathy

A

Assiut University

Status

Unknown

Conditions

Renal Scan in Suspected Obstructive Uropathy in Adult Hydronephrotic Patient

Treatments

Drug: Furosemide

Study type

Observational

Funder types

Other

Identifiers

NCT04564469
F+0 Vs F-15 in renal scan

Details and patient eligibility

About

Evaluation of the influence of the diuretic injection timing (F+0 Vs F-15) on the dynamic 99mTc- DTPA renal scintigraphy for the diagnosis of suspected obstructive uropathy in adult hydronephrotic patients.

Full description

Obstructive uropathy can be defined as any blockage of urine drainage from the kidney (renal calyces or renal pelvis), ureter, or bladder. As a result of the blockage, urine backs up into the kidneys, causing dilatation of the ureter, renal pelvis, and renal calyces, which can damage the kidney if it is not treated. The appearance of dilated or enlarged renal pelvis and calyces is referred to as hydronephrosis and is a symptom of obstructive uropathy.

Diuresis renography(renal scan with using of diuretic drug such as furosemide) is non-invasive test which is based on a high endogenous rate of urine flow stimulated by the administration of furosemide. Interpretation of the test is based on the rate of washout of the radiopharmaceutical from the collecting system in the upper urinary tract.

A number of different protocols exist in terms of the timing of furosemide injection, (F+0) protocol in which furosemide is injected at the same time of radiotracer administration &( F - 15)protocol in which furosemide is administered 15 min before tracer administration.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients ≥ 18 years.
  • Patients with hydronephrosis (unilateral or bilateral) referred for renal scan.
  • Patients able to sleep in a fixed position for 20 minutes.

Exclusion criteria

  • Severely impaired renal function.
  • Advanced hydronephrosis
  • Pregnancy.

Trial contacts and locations

0

Loading...

Central trial contact

Mohamed Mekkawy; walaa gamal fathy, Resident doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems